Wilson Sonsini Goodrich & Rosati advised General Atlantic on IP matters related to the transaction. Verdiva Bio Limited announced its launch as a clinical-stage biopharmaceutical company...
Verdiva Bio’s $410 Million Series A Financing Round
Prudentia Sciences’ $7 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised Prudentia Sciences on the transaction. Prudentia Sciences, an AI-powered technology platform for life sciences, emerged from stealth supported by $7...
Light Horse Therapeutics’ Collaboration with Novartis
Wilson Sonsini Goodrich & Rosati advised Light Horse Therapeutics on the transaction. Light Horse Therapeutics, a developer of small molecule therapeutics, announced its multi-target collaboration with...
Bolt Medical’s $900 Million of Acquisition of Boston Scientific
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
KKR’s Acquisition of Dawsongroup
Simpson Thacher & Bartlett is advising affiliates of KKR in the transaction, and Kirkland & Ellis is advising KKR on the financing for the acquisition. KKR...
Atlas Energy Solutions’ $220 Million Acquisition of Moser Energy Systems
Vinson & Elkins advised Atlas Energy Solutions, Inc. on the transaction, and Katten Muchin Rosenman advised Moser Acquisition, Inc. Atlas Energy Solutions, Inc. (“Atlas”) announced the...
Clutch’s $65 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented Clutch in the transaction. Clutch, a FinTech company, announced the successful completion of its $65 million Series B funding...
Insilico’s License Agreement with Menarini Group
Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction. Menarini Group, a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc., a wholly-owned...
Alleviant Medical’s $90 Million Equity Financing
Wilson Sonsini Goodrich & Rosati advised Alleviant Medical on the transaction. Alleviant Medical, Inc., a privately held medical device company, announced a $90 million financing to...
P180’s Acquisition of Majority Stake in Vince Holding Corp.
Ropes & Gray represented Vince Holding Corp. in the transaction. P180, a new luxury apparel venture, announced its acquisition of a majority stake in Vince Holding...
Frontenac’s $900 Million Closing of Oversubscribed Fund XIII
Kirkland & Ellis advised Frontenac on the deal. Chicago-based private equity firm Frontenac announced the close of its 13th fund, Frontenac XIII Private Capital L.P. (“Frontenac...
Gesynta Pharma’s Investment Round
Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal. Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured...